Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody.
Renee N DonahueLauren M LeponeItalia GrengaCaroline JochemsMassimo FantiniRavi A MadanChristopher R HeeryJames L GulleyJeffrey SchlomPublished in: Journal for immunotherapy of cancer (2017)
ClinicalTrials.gov identifier: NCT01772004 (first received: 1/14/13; start date: January 2013) and NCT00001846 (first received date: 11/3/99; start date: August 1999).